Inventor · disambiguated record
Ming Zhou
Also filed as: ZHOU MING · ZHOU MING-MING
38 granted patents·23 pending applications·182 citations·filing 2000–2025
96Inventor score
Files withSAREPTA THERAPEUTICS INC19ICAHN SCHOOL MED MOUNT SINAI5SINAI SCHOOL MEDICINE4HANSON GUNNAR JAMES3JOYANT PHARMACEUTICALS INC3
Top patents by PatentIndex Score
61 records- 0196US11097011B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·4 cites·17 claims
- 0295US8779128B2Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsHANSON GUNNAR J·Filed 2011·Granted Jul 15, 2014·65 cites·32 claims
- 0394US11672871B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·2 cites·26 claims
- 0494US7645857B2Methods of indentifying modulators of the FGF receptorSINAI SCHOOL MEDICINE·Filed 2005·Granted Jan 12, 2010·26 cites·2 claims
- 0593US10675356B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2016·Granted Jun 9, 2020·6 cites·34 claims
- 0693US9278987B2Functionally-modified oligonucleotides and subunits thereofSAREPTA THERAPEUTICS INC·Filed 2012·Granted Mar 8, 2016·12 cites·16 claims
- 0790US9469664B2Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsSAREPTA THERAPEUTICS INC·Filed 2014·Granted Oct 18, 2016·6 cites·18 claims
- 0889US9790499B2Functionally-modified oligonucleotides and subunits thereofSAREPTA THERAPEUTICS INC·Filed 2016·Granted Oct 17, 2017·3 cites·16 claims
- 0987US7851620B2Methods for preparing diazonamidesUNIV TEXAS·Filed 2008·Granted Dec 14, 2010·5 cites·22 claims
- 1086US7589167B2ZA loops of bromodomainsDAVID GLADSTONE INST J·Filed 2001·Granted Sep 15, 2009·33 cites·2 claims
- 1184US12239715B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·0 cites·27 claims
- 1282US10344281B2Functionally-modified oligonucleotides and subunits thereofSAREPTA THERAPEUTICS INC·Filed 2017·Granted Jul 9, 2019·1 cites·16 claims
- 1382US8551955B2Dimeric Smac mimeticsSUN HAIZHOU·Filed 2010·Granted Oct 8, 2013·4 cites·20 claims
- 1478US11208655B2Functionally-modified oligonucleotides and subunits thereofSAREPTA THERAPEUTICS INC·Filed 2019·Granted Dec 28, 2021·1 cites·16 claims
- 1578US7960420B2Diazonamide analogs with improved solubilityJOYANT PHARMACEUTICALS INC·Filed 2008·Granted Jun 14, 2011·4 cites·27 claims
- 1678US2022127613A1Functionally-Modified Oligonucleotides And Subunits ThereofSAREPTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1776US11572405B2Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 7, 2023·2 cites·28 claims
- 1876US2025057965A1Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1974US7989482B2Indoline anti-cancer agentsJOYANT PHARMACEUTICALS INC·Filed 2009·Granted Aug 2, 2011·2 cites·18 claims
- 2073US8153619B2Diazonamide analogsHANSON GUNNAR JAMES·Filed 2009·Granted Apr 10, 2012·2 cites·24 claims
- 2172US8846734B2Diazonamide analogsJOYANT PHARMACEUTICALS INC·Filed 2013·Granted Sep 30, 2014·1 cites·9 claims
- 2271US11046741B2Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·1 cites·38 claims
- 2371US2021139897A1Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsSAREPTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2468US2025195667A1Phosphorodiamidate morpholino oligomer conjugatesSAREPTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2567US2023322877A1Human neuregulin-1 (nrg-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2667US2025290069A1Exon skipping oligomers for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2766US10760078B2Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsSAREPTA THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·0 cites·24 claims
- 2864US11718652B2Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 8, 2023·0 cites·35 claims
- 2963US12378210B2Pharmaceutical composition comprising tizoxanide and pharmaceutical use thereofBEIJING JUNKE HUAYUAN MED TECH CO LTD·Filed 2021·Granted Aug 5, 2025·0 cites·15 claims
- 3063US2023279096A1Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3163US2020362339A1Processes for preparing phosphorodiamidate morpholino oligomers via fast-flow synthesisSAREPTA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3262US9884806B2Cyclic vinylogous amides as bromodomain inhibitorsICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Feb 6, 2018·0 cites·20 claims
- 3361US10202602B2Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsSAREPTA THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·0 cites·21 claims
- 3461US2024417429A1Compositions and methods for skipping exon 45 in duchenne muscular dystrophyENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3560US2025289851A1Cyclic peptides for delivering therapeuticsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3660US2022251551A1Exon skipping oligomers for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3758US8173696B2Inhibitors of cysteine proteases and methods of use thereofSILES ROGELIO·Filed 2008·Granted May 8, 2012·2 cites·19 claims
- 3858US7108984B2Methods of identifying modulators of the FGF receptorSINAI SCHOOL MEDICINE·Filed 2001·Granted Sep 19, 2006·0 cites·1 claims
- 3956US7982051B2Methods for preparing diazonamidesUNIV TEXAS·Filed 2010·Granted Jul 19, 2011·0 cites·9 claims
- 4054US8334311B2Indoline anti-cancer agentsHANSON GUNNAR JAMES·Filed 2011·Granted Dec 18, 2012·0 cites·19 claims
- 4154US8299268B2Methods for preparing diazonamidesHANSON GUNNAR·Filed 2011·Granted Oct 30, 2012·0 cites·14 claims
- 4253US8476256B2Diazonamide analogsHANSON GUNNAR JAMES·Filed 2012·Granted Jul 2, 2013·0 cites·23 claims
- 4353US2010249184A1Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interactionSINAI SCHOOL MEDICINE·Filed 2008·Application pending·0 cites
- 4452US2013344026A1Dimeric Smac MimeticsSUN HAIZHOU·Filed 2013·Application pending·0 cites
- 4550US10280408B2Method of suppressing gene transcription through histone lysine methylationICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted May 7, 2019·0 cites·17 claims
- 4649US2015133434A1Compositions and Methods for Reactivating Latent Immunodeficiency VirusDAVID GLADSTONE INST·Filed 2013·Application pending·0 cites
- 4747US10351511B2Cyclic vinylogous amides as bromodomain inhibitorsICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Granted Jul 16, 2019·0 cites·18 claims
- 4847US2019030176A1Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4946US2002197685A1Amplification of heterogeneous full-length mRNAFiled 2002·Application pending·0 cites
- 5045US12473263B2Bicyclic inhibitors of CBX chromodomainsICAHN SCHOOL MED MOUNT SINAI·Filed 2020·Granted Nov 18, 2025·0 cites·7 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ming Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →